Liposomal Encapsulation Reduces the Cytotoxic Effects of Gramicidin S in Monolayer and Spheroid Fibroblast Cultures
Antibiotics · 06.02.2026 · 15 (2) · 177
DOI: 10.3390/antibiotics15020177 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antibiotics, online erschienen am 06.02.2026. Verfasst von Ihor Perepelytsia und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Medical Biophysics, School of Radio Physics, Biomedical Electronics and Computer Systems, V. N. Karazin Kharkiv National …. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education and Science of Ukraine.
Abstract (Originalsprache)
Background/Objectives: Gramicidin S (GS) is a cyclic antimicrobial peptide with strong antibacterial activity but significant cytotoxicity toward mammalian cells. This study evaluated GS-induced cytotoxicity in L929 fibroblast cells using both traditional 2D monolayer cultures and more physiologically relevant 3D spheroid models, and assessed whether liposomal encapsulation could mitigate toxicity and improve biocompatibility.
Methods
L929 cells were cultured in monolayers and spheroids and treated with free GS or GS encapsulated in liposomes of varying lipid compositions. Cell viability and morphology were evaluated after 24 h of exposure using standard cytotoxicity assays.
Results
Control liposomes, regardless of tested lipid type or concentration, showed no adverse effects on cell morphology or viability. Free GS caused pronounced, dose-dependent cytotoxicity in monolayers, decreasing viability to 11.0 ± 1.9% and 0.5 ± 1.1% at 50 and 75 µg/mL, respectively. By contrast, encapsulation in liposomes significantly reduced toxicity (p < 0.05), preserving 80.3–82.2% viability at 75 µg/mL depending on formulation, corresponding to protection factors exceeding 160-fold (80.3% vs. 0.5%). Spheroid cultures showed slightly higher resistance to GS; free GS reduced viability to 2.9%, while liposomal GS preserved it above 84.8%, depending on lipid composition.
Conclusions
Liposomal encapsulation effectively reduces GS-induced cytotoxicity, likely by limiting direct membrane disruption. Moreover, spheroid models provide a more physiologically relevant and predictive platform for toxicity testing, while the results support nanoliposomes as a practical delivery strategy to enhance the safety of antimicrobial peptides during preclinical development.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Molecular and Medical Biophysics, School of Radio Physics, Biomedical Electronics and Computer Systems, V. N. Karazin Kharkiv National University, 4 Svobody Sq, 61022 Kharkiv, Ukraine.
- Department of Cryoendocrinology, Institute for Problems of Cryobiology and Cryomedicine of the NAS of Ukraine, 23 Pereyaslavska St., 61016 Kharkiv, Ukraine.
- Advanced Research Unit, ELTEK S.p.A., 15033 Casale Monferrato, Italy.
- Department of Life Sciences and Systems Biology, University of Turin, Via Accademia Albertina 13, 10123 Turin, Italy.
ORCID-Profile: Volodymyr Berest, Larysa Sichevska, Oleksii Skorokhod
Förderung
- Ministry of Education and Science of Ukraine
Zitieren
APA
Perepelytsia, I., Bozhok, G., Berest, V., Gallo, V., Pizzi, M., Sichevska, L., & Skorokhod, O. (2026). Liposomal Encapsulation Reduces the Cytotoxic Effects of Gramicidin S in Monolayer and Spheroid Fibroblast Cultures. Antibiotics, 15(2), 177. https://doi.org/10.3390/antibiotics15020177
Vancouver
Perepelytsia I, Bozhok G, Berest V, Gallo V, Pizzi M, Sichevska L, et al. Liposomal Encapsulation Reduces the Cytotoxic Effects of Gramicidin S in Monolayer and Spheroid Fibroblast Cultures. Antibiotics. 2026;15(2):177. doi:10.3390/antibiotics15020177
BibTeX
@article{Perepelytsia2026,
author = {Perepelytsia, Ihor and Bozhok, Galyna and Berest, Volodymyr and Gallo, Valentina and Pizzi, Marco and Sichevska, Larysa and Skorokhod, Oleksii},
title = {Liposomal Encapsulation Reduces the Cytotoxic Effects of Gramicidin S in Monolayer and Spheroid Fibroblast Cultures},
journal = {Antibiotics},
year = {2026},
volume = {15},
number = {2},
pages = {177},
doi = {10.3390/antibiotics15020177}
}
EUVIMED